About Vericiguat micronized
            
            Class: | Soluble guanylate cyclase (sGC) stimulator  
Use: | Vericiguat is indicated to reduce the risk of cardiovascular death and heart failure hospitalization following a hospitalization for heart failure or need for outpatient intravenous diuretics in adults with symptomatic chronic heart failure and ejection fraction less than 45%.  
Adult dose: | The recommended starting dose is 2.5 mg orally once daily with food. Double the dose approximately every 2 weeks to reach the target maintenance 
         
        
            
                
                
                    
                        Drug Class
                    
                    Soluble guanylate cyclase (sGC) stimulator
                 
                
                
                    
                        Uses & Indications
                    
                    Vericiguat is indicated to reduce the risk of cardiovascular death and heart failure hospitalization following a hospitalization for heart failure or need for outpatient intravenous diuretics in adults with symptomatic chronic heart failure and ejection fraction less than 45%.
                 
                
                
                    
                        Storage Requirements
                    
                    Store at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F).
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: Bayer AG, GERMANY
                    
                    
                    Package Size
                    14's
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 257.00
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        The recommended starting dose is 2.5 mg orally once daily with food. Double the dose approximately every 2 weeks to reach the target maintenance dose of 10 mg once daily, as tolerated by the patient.
                    
                    
                        Pediatric Dose
                    
                    
                        Safety and efficacy have not been established in pediatric patients.
                    
                 
                
                
                    
                        Side Effects
                    
                    Common side effects include hypotension, anemia, and dizziness.
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Contraindicated in patients with concomitant use of other soluble guanylate cyclase stimulators or phosphodiesterase-5 inhibitors, and in patients with hypersensitivity to any component of the product.
         
        
        
            
                Important Warnings
            
            Monitor blood pressure regularly as vericiguat can cause symptomatic hypotension. Use caution in patients with volume depletion or severe renal impairment. Avoid use during pregnancy due to potential harm to the fetus.
         
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.